Danicopan (Voydeya, Alexion) is indicated as 'an add-on to ravulizumab or eculizumab for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have residual haemolytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback